Melonga: From Idea to Impact
Melonga was born from a simple but serious belief: men deserve better, evidence-based options to improve their intimate health — without shame, pills, or false promises.
After years of research and clinical collaboration, we’ve built a digital therapeutic that helps men overcome premature ejaculation through a structured, personalised, 12-week program.
🧱 Foundation in Science, Not Stigma
Too often, PE is trivialized or ignored. But it’s real — and manageable. Melonga combines decades of psychosexual therapy principles, behavioral science, and clinical input to offer a serious, CE-marked solution.
🌍 Built by leading Clinicians, Sexologists and Psychotherapists from all over the world
-
Developed in Singapore and the Netherlands by experts from Germany, the USA, Belgium, Finland and India
-
Clinically evaluated in Germany (more countries coming soon)
-
Designed for privacy, performance, and long-term impact
-
CE-marked Class I medical device in six EU countries
❤️ Bootstrapped by People Who Care
We’re not backed by large investors. Melonga is built by clinicians, psychotherapists, sexologists, engineers, and health entrepreneurs who care deeply about real results.
🚀 What’s Next?
-
We will continue to improve the app and make it simpler to use, without deviating from its core clinically-validated therapeutic DNA.
-
Start working with payors and insurers so that our selected customers benefit from the Melonga app with little to no cost.
-
More clinical trials and partnerships in 2025–2026